Michael Belkin

Prof. Belkin, one of NovaSight's founders, is Professor Emeritus in the Department of Ophthalmology at Tel Aviv University, and a senior advisor to the Singapore Eye Research Institute. He is also the Co-founder and former president of the Israel Society of Eye and Vision Research. He was also Head of Pediatric Ophthalmology Services at the Hadassah University Hospital and Sheba Medical Center. Prof. Belkin holds over 25 patents, has published more than 250 scientific publications, innovated the technology behind Optonol, and served as the company’s CMO prior to its acquisition by Alcon for over US$200 million. Prof. Belkin was also Head of Research and Development for the Medical Department of the Israeli Military, and Chairman of the Tel Aviv University Department of Ophthalmology.